Tsutomu Yoshikawa Selected Research

Matrix Metalloproteinases (MMPs)

7/2011	Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
5/2003	[Alterations in sympathoadrenal system in congestive heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Yoshikawa Research Topics

Disease

64	Heart Failure 11/2023 - 01/2002
18	Myocardial Infarction 01/2023 - 01/2003
10	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2016 - 01/2002
7	Death (Near-Death Experience) 05/2024 - 02/2009
7	Fibrosis (Cirrhosis) 01/2022 - 10/2004
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 11/2008
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 01/2002
6	Ventricular Tachycardia 01/2018 - 01/2002
6	Ventricular Remodeling 01/2011 - 04/2003
5	Atrial Fibrillation 01/2011 - 11/2002
5	Infarction (Infarctions) 02/2009 - 01/2003
4	Aortic Dissection 01/2023 - 06/2005
4	Anemia 06/2021 - 05/2010
4	Abdominal Aortic Aneurysm 05/2012 - 07/2011
4	Heart Rupture 12/2010 - 01/2003
3	Unstable Angina 01/2023 - 09/2002
3	Hyponatremia 10/2019 - 01/2018
3	Chronic Renal Insufficiency 08/2019 - 08/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 11/2002
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018 - 01/2016
3	Sudden Death 01/2018 - 09/2002
3	Necrosis 08/2011 - 02/2009
3	ST Elevation Myocardial Infarction 09/2010 - 11/2009
3	Convalescence 05/2010 - 10/2008
2	Takotsubo Cardiomyopathy 11/2023 - 02/2019
2	Malnutrition (Nutritional Deficiencies) 01/2023 - 01/2022
2	Chest Pain (Chest Pains) 02/2019 - 01/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 01/2016
2	Ventricular Fibrillation 01/2018 - 11/2009
2	Cardiomyopathies (Cardiomyopathy) 01/2015 - 03/2004
2	Inflammation (Inflammations) 01/2015 - 08/2011
2	Left Ventricular Dysfunction 01/2014 - 12/2010
2	Diabetic Cardiomyopathies 01/2014 - 01/2011
2	Myocarditis (Carditis) 05/2012 - 04/2009
2	Insulin Resistance 08/2011 - 01/2011
2	Obesity 08/2011 - 01/2011
2	Aneurysm (Aneurysms) 08/2011 - 07/2011
2	Hypertension (High Blood Pressure) 02/2011 - 11/2002
2	Neoplasms (Cancer) 10/2008 - 09/2008
2	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2007 - 11/2002

Drug/Important Bio-Agent (IBA)

16	C-Reactive ProteinIBA 02/2019 - 01/2003
14	AutoantibodiesIBA 12/2016 - 01/2002
10	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2019 - 08/2004
8	Carvedilol (Coreg)FDA LinkGeneric 03/2020 - 10/2003
7	CytokinesIBA 03/2012 - 09/2002
5	Indicators and Reagents (Reagents)IBA 02/2023 - 01/2015
5	DiureticsIBA 01/2021 - 01/2009
5	Messenger RNA (mRNA)IBA 08/2011 - 10/2004
5	Adenosine Triphosphatases (ATPase)IBA 01/2011 - 01/2002
4	Eplerenone (Inspra)FDA LinkGeneric 01/2022 - 01/2014
4	NitrogenIBA 12/2019 - 01/2016
4	Urea (Carbamide)FDA LinkGeneric 12/2019 - 01/2016
4	GadoliniumIBA 01/2018 - 01/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 07/2006
4	EnzymesIBA 10/2011 - 11/2002
4	Metoprolol (Toprol-XL)FDA LinkGeneric 08/2010 - 10/2003
3	AntibodiesIBA 06/2023 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2011
3	Mineralocorticoid Receptor AntagonistsIBA 01/2023 - 12/2017
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2022 - 01/2018
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2004
3	Hemoglobins (Hemoglobin)IBA 06/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 05/2012 - 02/2009
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2012 - 10/2004
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2011 - 10/2008
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2010 - 01/2002
3	beta Adrenergic ReceptorsIBA 05/2006 - 05/2003
2	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2022
2	PotassiumIBA 12/2022 - 11/2002
2	Uric Acid (Urate)IBA 11/2020 - 01/2020
2	CreatinineIBA 12/2019 - 08/2019
2	SodiumIBA 10/2019 - 01/2016
2	CatecholaminesIBA 02/2019 - 12/2016
2	Tryptophan (L-Tryptophan)FDA Link 12/2016 - 01/2011
2	AldosteroneIBA 04/2015 - 05/2005
2	Type 1 Angiotensin ReceptorIBA 01/2014 - 05/2005
2	Troponin T (Troponin T1)IBA 01/2014 - 05/2010
2	Cholinergic ReceptorsIBA 05/2012 - 07/2004
2	Interleukin-10 (Interleukin 10)IBA 03/2012 - 07/2006
2	human NPPA protein (carperitide)IBA 01/2012 - 11/2008
2	Matrix Metalloproteinases (MMPs)IBA 07/2011 - 05/2003
2	HMGB1 Protein (HMG1)IBA 05/2011 - 02/2009
2	omega-Chloroacetophenone (Mace)IBA 03/2011 - 05/2010
2	Collagen Type I (Type I Collagen)IBA 01/2011 - 10/2004
2	CalciumIBA 01/2011 - 04/2009
2	Immunoglobulin G (IgG)IBA 01/2011 - 07/2010
2	Muscarinic M2 ReceptorIBA 01/2011 - 04/2009
2	Troponin IIBA 01/2011 - 04/2009
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2010 - 12/2008
2	Malondialdehyde (Propanedial)IBA 05/2010 - 12/2008
2	Interleukin-6 (Interleukin 6)IBA 05/2010 - 12/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2008 - 02/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2008 - 10/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008 - 10/2004

Therapy/Procedure

27	Therapeutics 10/2023 - 09/2002
6	Patient Readmission 05/2024 - 01/2019
2	Drug Therapy (Chemotherapy) 11/2023 - 01/2023
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 01/2018